All filters
Slidesets
Long Term Pemetrexed-based Cancer Treatment Leads to Nephrotoxicity - Nikki de Rouw
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Prediction of Capecitabine induced Severe Toxicity using Machine Learning Techniques - Maël Steunou
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
The Long and Winding Road of the Clinical Introduction of a Biomarker - Jack Schalken, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
The Use of Radiolabeled and Fluorescent Monoclonal Antibodies for Molecular Imaging in Oncology - Annelies Jorritsma-Smit, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Epigenetic Regulation of OCTN1-mediated Cytarabine Transport in Acute Myeloid Leukemia - Jason Anderson
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
How System Pharmacology Can Facilitate Clinical Drug Development in Oncology - Piet van der Graaf, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Impact of Immortal Time and Selection Bias on Exposure-response Modelling - Mats Karlsson, PhD, FCP, FISoP
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Challenges in the Development of Immunotherapy - Candice Jamois, PharmD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Optimal Study Design of Oncology Trials - Patricia LoRusso, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Pharmacokinetics and Safety of Pazopanib in Frail Elderly Patients - Félicien Le Louedec
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Effects of Dietary Restriction in Cancer Patients Receiving Irinotecan - Ruben van Eerden
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Oral Targeted Oncolytics - Neeltje Steeghs, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Dose Individualization Potential for Checkpoint Inhibitors - Stijn Koolen, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib - Koen Hussaart
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Correlation Between Sunitinib Exposure and Toxicity in a Real-life Patient Cohort - Kim Westerdijk
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Drug - Food Interaction an Unrealized Potential - Nielka van Erp, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2019
Slidesets
Immunological response after stopping Nucs- Andre Boonstra
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Virological biomarkers in patients stopping Nucs- Florian van Bommel, MD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Review of the FDA/EMA HBV Endpoints Meeting- Fabien Zoulim, MD, PhD
Presented at:
International Workshop on HBV Cure 2019
Slidesets
Are ALT Flares Associated with Improved Virological Clearance- Harry Janssen, MD, PhD
Presented at:
International Workshop on HBV Cure 2019